Company Name: Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development and commercialization of drugs that target G protein-coupled receptors (GPCRs). The company’s first approved drug is a weight management product and its pipeline includes product candidates for conditions such as:
- Ulcerative colitis
- Pulmonary arterial hypertension (PAH)
Ticker Symbol: ARNA (NASDAQ)
Company Website: www.arenapharm.com
Social Media: Arena Pharmaceuticals LinkedIn Page
Headquarters: San Diego, CA